BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 27488224)

  • 1. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
    Bhandari R; Pant ND; Poudel A; Sharma M
    BMC Res Notes; 2016 Aug; 9():390. PubMed ID: 27488224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K; Pant ND; Neupane B; Belbase A; Baidhya R; Shrestha RK; Lekhak B; Bhatta DR; Jha B
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):62. PubMed ID: 28927454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal.
    Chander A; Shrestha CD
    BMC Res Notes; 2013 Nov; 6():487. PubMed ID: 24274894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
    Chaudhary P; Bhandari D; Thapa K; Thapa P; Shrestha D; Chaudhary HK; Shrestha A; Parajuli H; Gupta BP
    J Nepal Health Res Counc; 2016 May; 14(33):111-115. PubMed ID: 27885293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda.
    Kateregga JN; Kantume R; Atuhaire C; Lubowa MN; Ndukui JG
    BMC Pharmacol Toxicol; 2015 Jun; 16():14. PubMed ID: 26031914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended spectrum beta-lactamase producing multidrug resistant urinary isolates from children visiting Kathmandu Model Hospital.
    Dhakal S; Manandhar S; Shrestha B; Dhakal R; Pudasaini M
    Nepal Med Coll J; 2012 Jun; 14(2):136-41. PubMed ID: 23671965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
    Neupane S; Pant ND; Khatiwada S; Chaudhary R; Banjara MR
    Antimicrob Resist Infect Control; 2016; 5():5. PubMed ID: 26885364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
    Tenover FC; Raney PM; Williams PP; Rasheed JK; Biddle JW; Oliver A; Fridkin SK; Jevitt L; McGowan JE;
    J Clin Microbiol; 2003 Jul; 41(7):3142-6. PubMed ID: 12843054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended Spectrum β-lactamase (ESBL) Producing Multi Drug Resistant (MDR) Urinary Pathogens in a Children Hospital from Nepal.
    Sharma KR; Bhandari P; Adhikari N; Tripathi P; Khanal S; Tiwari BR
    Kathmandu Univ Med J (KUMJ); 2018; 16(62):151-155. PubMed ID: 30636756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of CTX-M
    Koirala S; Khadka S; Sapkota S; Sharma S; Khanal S; Thapa A; Khadka DK; Poudel P
    Biomed Res Int; 2021; 2021():9958294. PubMed ID: 34212045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM; Hope R; Mushtaq S; Warner M
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L; Brossier F; Sougakoff W; Jarlier V
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of extended spectrum beta lactamase in urinary isolates.
    Tankhiwale SS; Jalgaonkar SV; Ahamad S; Hassani U
    Indian J Med Res; 2004 Dec; 120(6):553-6. PubMed ID: 15654142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
    El Aila NA; Al Laham NA; Ayesh BM
    BMC Infect Dis; 2023 Feb; 23(1):99. PubMed ID: 36803466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.